美国、礼来、诺和诺德宣布关于降低GLP-1减肥药价格的协议，两家公司定价每个月245美元

Core Insights - A new agreement has been announced between the U.S., Eli Lilly, and Novo Nordisk to lower the prices of GLP-1 weight loss medications, with both companies setting the price at $245 per month [1] Pricing Strategy - The monthly price of $245 for GLP-1 medications represents a significant reduction aimed at increasing accessibility for patients [1]